Study on the cytotoxic T lymphocytes of mice treated with leukemia vaccine

赵万红,张王刚,何爱丽,王一理,耿宜萍,田玮,宋长琐

DOI: https://doi.org/10.3969/j.issn.1671-8259.2003.01.016

2003-01-01

Abstract:Objective: To study the cytotoxicity of cytotoxic T lymphocytes (CTL) derived from C57BL/6 mice treated with the leukemia vaccine prepared by us. Methods: We established leukemia burden mice and prepared three types of leukemia vaccine, which were administered on the mice respectively. The MTT colorimetric method was adopted 2 and 4 weeks later to measure the cytotoxicity of CTL derived from the mice which accepted immunotherapy or prevention. Then we compared it with that of control group. Results: 1 With the growth of leukemia cells in the mice, the cytotoxicity of CTL was severely depressed. 2 The tumor vaccine prepared from inactivated tumor cells, IFA and cytokines (rGM-CSF, rIL-2 and rIL-6) promoted the cellular immunity of tumor burden mice more efficiently than the tumor vaccine made from either inactivated tumor cells, IFA or inactive tumor cells themselves alone. Conclusion: The tumor vaccine prepared with inactive tumor cells, IFA and cytokines (rGM-CSF, rIL-2 and rIL-6) can activate the specific cellular immunity. Therefore, the tumor vaccine provides a promising future in the active specific immunotherapy against hematopoietic tumors.